Reactive oxygen species as mediators of calcium signaling by angiotensin II: Implications in vascular physiology and pathophysiology

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1302-1314

  Touyz, Rhian M ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN; CALCIUM ION; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXYNITRITE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO KINASE; SUPEROXIDE; TRANSCRIPTION FACTOR;

CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; ENZYME ACTIVITY; HUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANGIOTENSIN II; ANIMALS; CALCIUM; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PROTEIN-TYROSINE-PHOSPHATASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 24144477287     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1302     Document Type: Review

References (107)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004.
2. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25:155-161, 1995.
3. Anderson JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, and Moller NP. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell 21: 7117-7136, 2001.
4. Azumimi H, Inoue N, and Takeshita S. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100: 1494-1498, 1999.
5. - in vascular smooth muscle cells. Circ Res 77: 29-36, 1995.
6. Babior BM, Lambeth JD, and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344, 2002.
7. Bagi Z and Koller A. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin. J Vasc Res 40: 47-57, 2003.
8. Banfi B, Clark RA, Steger K, and Krause K-H. Two novel proteins activate superoxide generation by the NADPH oxidase Nox1. J Biol Chem 278: 3510-3513, 2003.
9. Barlow RS and White RE. Hydrogen peroxide relaxes porcine coronary arteries by stimulating BKCa channel activity. Am J Physiol 275(4 Pt 2): H1283-H1289, 1998.
10. Begum N, Ragolia L, Rienzie J, McCarthy M, and Duddy N. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. J Biol Chem 273: 25164-25170, 1998.
11. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81: 999-1030, 2001.
12. Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, Holland SM, Gorlach A, and Busse R. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 32: 1116-1122, 2002.
13. Brigelius-Flohe R, Banning A, Kny M, and Bol GF. Redox events in interleukin-1 signaling. Arch Biochem Biophys 423: 66-73, 2004.
14. Chamseddine AH and Miller FJ Jr. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 285: H2284-H2289, 2003.
15. Channon KM and Guzik TJ. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53: 515-524, 2002.
16. Chen X, Touyz RM, Park JB, and Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NAD(P)H oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38: 606-611, 2001.
17. Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, and Luscher TF. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 21: 496-502, 2001.
18. Darley-Usmar V, Wiseman H, and Halliwell B. Nitric oxide and oxygen radicals, a question of balance. FEBS Lett 369: 13-15, 1995.
19. Deshpande NN, Sorescu D, Seshiah P, Ushio-Fukai M, Akers M, Yin Q, and Griendling KK. Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal 4: 845-854, 2002.
20. 2+ stores and protein synthesis in human endothelial cells. Circ Res 76: 388-395, 1995.
21. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2001.
22. 2+ influx pathway of vascular endothelial cells. Am J Physiol 270: L954-L961, 1996.
23. Ermak G and Davies KJA. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38: 713-721, 2001.
24. Forman HJ and Torres M. Redox signaling in macrophages. Mol Aspects Med 22: 189-216, 2001.
25. Frank GD and Eguchi S. Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II. Antioxid Redox Signal 5: 771-780, 2003.
26. Fridovich I. Superoxide anion radical, superoxide dismutases, and related matters. J Biol Chem 272: 18515-18517, 1997.
27. Fukata Y, Amano M, and Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39, 2001.
28. Gao YJ and Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134: 1639-1646, 2001.
29. Gauss KA, Mascolo PL, Siemsen DW, Nelson LK, Bunger PL, Pagano PJ, and Quinn MT. Cloning and sequencing of rabbit leukocyte NADPH oxidase genes reveals a unique p67(phox) homolog. J Leukoc Biol 71: 319-328, 2002.
30. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
31. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
32. Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H, and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92: 80-86, 2003.
33. 2+ pump. Am J Physiol 269(3 Pt 1): C546-C553, 1995.
34. 2+ pump in pig coronary artery smooth muscle. Am J Physiol Cell Physiol 284: C294-C301, 2003.
35. Guillemot L, Levy A, Zhao ZJ, Bereziat G, and Rothhut B. The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells. J Biol Chem 275: 26349-26358, 2000.
36. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1562, 2002.
37. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, and Takeshita A. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 93: 767-775, 2003.
38. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 1-8, 2004.
39. Hu Q, Corda S, Zweier JL, Capogrossi MC, and Ziegelstein RC. Hydrogen peroxide induces intracellular calcium oscillations in human aortic endothelial cells. Circulation 91: 268-215, 1998.
40. Intengan HD and Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38(3 Pt 2): 581-587, 2001.
41. 2. Eur J Biochem 267: 1933-1944, 2000.
42. Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, and Takeshita A. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 39: 245-250, 2002.
43. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20: 443-448, 1996.
44. Kobayashi N, Nakano S, Mita S-I, Kobayashi T, Honda T, Tsubokou Y, and Matsuoka H. Involvement of Rho-kinase pathway for Ang II-induced plasminogen activator inhibitor gene expression and cardiovascular remodeling in hypertensive rats. J Pharmacol Exp Ther 301: 459-466, 2002.
45. Kontos HA, Wei EP, Christman CW, Levasseur JE, Povlishock JT, and Ellis EF. Free oxygen radicals in cerebral vascular responses. Physiologist 26: 165-169, 1983.
46. Kourie JI. Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 275: C1-C24, 1998.
47. Landmesser U and Harrison DG. Oxidative stress and vascular damage in hypertension. Coron Artery Dis 12: 455-461, 2001.
48. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
49. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
50. Lassegue B. Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
51. 2 regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33: 1121-1132, 2002.
52. Lounsbury KM, Hu Q, and Ziegelstein RC. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 28: 1362-1369, 2000.
53. Luft FC. Mechanisms and cardiovascular damage in hypertension. Hypertension 37: 594-598, 2001.
54. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, and Takeshita A. Possible involvement of Rhokinase in the pathogenesis of hypertension in humans. Hypertension 38: 1307-1310, 2001.
55. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, and Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
56. Milstien S and Katusic Z. Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem Biophys Res Commun 263: 681-684, 1999.
57. 2+ dynamics in endothelial cells. Am J Physiol 253: C588-C598, 1987.
58. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki H, Kaibuchi K, and Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15: 1062-1064, 2001.
59. Nickenig G, Strehlow K, Baumer AT, Baudler S, Wassmann S, Sauer H, and Bohm M. Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression. Br J Pharmacol 131: 795-803, 2000.
60. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, and Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 12: 153-183, 2001.
61. Pi X, Yan C, and Berk BC. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res 94: 362-369, 2004.
62. Privratsky JR, Wold LE, Sowers JR, Quinn MT, and Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
63. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, and Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 98: 2572-2579, 1996.
64. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, Gonzalez R, Salaices M, and Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol 125: 1329-1335, 1998.
65. Rubanyi GM. Vascular effects of oxygen-derived free radicals. Free Radic Biol Med 4: 107-120, 1988.
66. Ruiz-Ortega M. Ruperez M, Esteban V, and Egido J. Molecular mechanisms of Ang II-induced vascular injury. Curr Hypertens Rep 5: 73-79, 2003.
67. Ruperez M, Ruiz-Ortega M, Esteban V, Lorenzo O, Mezzano S, Plaza JJ, and Egido J. Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 163: 1937-1947, 2003.
68. Saito Y and Berk BC. Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep 4: L167-L171, 2002.
69. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001.
70. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001
71. 2+-ATPase. Arch Biochem Biophys 246: 589-601, 1986.
72. Schnackenberg CG, Welch W, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 32: 59-64, 1999.
73. Schuijt MP, Tom B, de Vries R, Saxena PR, Sluiter W, van Kats JP, and Danser AHJ. Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II. A study in human and porcine arteries. J Hypertens 21: 2335-2344, 2003.
74. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity. Upstream mediators. Circ Res 91:406-413, 2002.
75. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, and Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.
76. Stralin P, Karlsson K, Johannson BO, and Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15: 2032-2036, 1995.
77. Suematsu M, Suzuki H, Delano FA, and Schmid-Schonbein GW. The inflammatory aspect of the microcirculaion in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 9: 259-276, 2002.
78. Suh YA, Arnold RS, and Lassegue B. Cell transformation by the superoxide-generating Mox-1. Nature 410: 79-82, 1999.
79. Suzuki Y, Ruiz-Ortega M, Gomez-Guerrero C, Tomino Y, and Egido J. Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrol Dial Transplant 18: 1423-1426, 2003.
80. 2+-ATPase of vascular smooth muscle sarcoplasmic reticulum. J Mol Cell Cardiol 25: 823-827, 1993.
81. Szocs K, Lassegue B, Sorescu D, Hilenski LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD, and Griendling KK. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 22: 21-27, 2002.
82. Tabet F, Savoia C, Schiffrin EL, andTouyz RM. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from SHR. J Cardiovasc Pharmacol 44: 1-9, 2004.
83. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003.
84. Torrecillas G, Boyano-Adanez MC, Medina J, Parra T, Griera M, Lopez-Ongil S, Arilla E, and Rodriguez-Puyol M, and Rodriguez-Puyol D. The role of hydrogen peroxide in the contractile response to angiotensin II. Mol Pharmacol 59: 104-112, 2001.
85. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep 5: 155-164, 2003.
86. Touyz RM. Activated oxygen metabolites: do they really play a role in angiotensin II-regulated vascular tone? J Hypertens 21: 2235-2238, 2003.
87. Touyz RM and Schiffrin EL. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. Hypertension 30(2 Pt 1): 222-229, 1997.
88. Touyz RM and Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34: 976-982, 1999.
89. Touyz RM and Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672, 2000.
90. Touyz RM and Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens 19: 1245-1254, 2001.
91. Touyz RM, Chen X, He G, Quinn MT, and Schiffrin EL. Expression of a gp91phox-containing leukocyte-type NADPH oxidase in human vascular smooth muscle cells-modulation by Ang II. Circ Res 90: 1205-1213, 2002.
92. Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MF, Virdis A, and Schiffrin EL. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens 20: 1127-1134, 2002.
93. Touyz RM, Yao G, and Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 981-987, 2003.
94. Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, and Schiffrin EL. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells-role of receptor tyrosine kinase transactivation. Can J Physiol Pharmacol 81: 159-167, 2003.
95. Turpaev KT. Reactive oxygen species and regulation of gene expression. Biochemistry 67: 281-292, 2002.
96. Ushio-Fukai M, Alexander RW, Akers M, and Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998.
97. Vasquez-Vivar J, Duquaine D, Whitsett J, Kalyanaraman B, and Rajagopalan S. Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants. Arterioscler Thromb Vasc Biol 22: 1655-1661, 2002.
98. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20: 940-948, 2000.
99. Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, and Schiffrin EL. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler Thromb Vasc Biol 23: 1352-1357, 2003.
100. Wei EP, Kontos HA, and Beckman JS. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxymtrite. Am J Physiol 271: H1262-H1266, 1996.
101. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
102. Xu D, Rovira II, and Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2: 251-252, 2002.
103. Xu Q, Liu Y, Gorospe M, Udelsman R, and Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97: 508-514, 1996.
104. 1 in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 360: 646-653, 1999.
105. Yermolaieva O, Brot N, Weissbach H, Heinemann SH, and Hoshi T. Reactive oxygen species and nitric oxide mediate plasticity of neuronal calcium signaling. Proc Natl Acad Sci USA 97: 448-453, 2000.
106. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 98: 24-27, 2002.
107. Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G, Kovesdi I, and Chen AF. Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108: 1238-1245, 2003.